Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 13.75
0.00 (0.00%)
Jun 17, 2026, 5:06 PM GMT
Creo Medical Group Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Creo Medical Group stock has a consensus rating of "Strong Buy" and an average price target of 50p. The average 1-year stock price forecast is 263.64% higher than the current stock price, while the lowest is 40p (+190.91%) and the highest is 70p (+409.09%).
Price Target: 50p (+263.64%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Creo Medical Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
9.10M
from 6.00M
Increased by 51.67%
Revenue Next Year
14.70M
from 9.10M
Increased by 61.54%
EPS This Year
-0.02
from 0.02
EPS Next Year
-0.01
from -0.02
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is GBP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.2M | ||
| Avg | 9.1M | ||
| Low | 9.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 53.3% | ||
| Avg | 51.7% | ||
| Low | 50.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -0.02 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |